Related Experiment Video
Updated: Sep 27, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Reclassification and risk stratification of embolic stroke of undetermined source by ASCOD phenotyping
Takao Hoshino1, Takafumi Mizuno1, Ayako Nishimura1
1Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Insights
Atherosclerosis, but not small-vessel disease or cardiac pathology, predicts recurrent vascular events in patients with embolic stroke of undetermined source (ESUS). ASCOD phenotyping aids risk prediction and management strategies for ESUS.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Vascular Biology
Background:
- Embolic stroke of undetermined source (ESUS) can involve underlying vascular diseases like atherosclerosis, small-vessel disease (SVD), and cardioembolic pathology.
- These common vascular conditions are not direct causes of stroke but contribute to risk.
Purpose of the Study:
- To determine the frequency and severity of atherosclerosis, SVD, and cardiac pathology in ESUS patients using ASCOD phenotyping.
- To evaluate the prognostic significance of these vascular diseases in ESUS.
Main Methods:
- A prospective observational study enrolled 221 ESUS patients within one week of stroke onset.
- Patients were followed for one year, with vascular diseases classified using the ASCOD system.
- The primary outcome was a composite of nonfatal stroke, nonfatal acute coronary syndrome, and vascular death.
Main Results:
- Atherosclerosis (ASCOD grade A2/A3) was present in 61.1% of patients and significantly increased the risk of vascular events (aHR 2.40).
- Small-vessel disease (S3) and cardiac pathology (C2/C3) did not show a significant association with recurrent vascular events.
- No significant differences in event risk were observed for SVD or cardiac pathology compared to their respective absence.
Conclusions:
- Atherosclerotic diseases (ASCOD grade A2/A3) are predictive of recurrent vascular events in ESUS patients.
- ASCOD phenotyping offers valuable insights for risk stratification and guiding management in ESUS.
- This classification system can help refine treatment strategies for patients with ESUS.
Background:
Common vascular diseases underlying stroke, including atherosclerosis, small-vessel disease (SVD), and cardioembolic pathology, can be present in patients with embolic stroke of undetermined source (ESUS), although these are not direct causes of stroke.
Aims:
To describe the frequency and degree of the three major diseases using atherosclerosis, SVD, cardiac pathology, other causes, and dissection (ASCOD) phenotyping and to assess their prognostic implications in ESUS.
Methods:
In this prospective observational study, 221 patients with ESUS within 1 week of onset were consecutively enrolled and followed up for 1 year. Vascular diseases associated with stroke were assessed using the ASCOD classification. The primary outcome was a composite of nonfatal stroke, nonfatal acute coronary syndrome, and vascular death.
Results:
Among 221 patients (mean age, 69.6 years; male, 59.7%), 135 (61.1%), 102 (46.2%), and 107 (48.4%) had any grade of atherosclerosis (A2 or A3), SVD (S3), and cardiac pathology (C2 or C3), respectively. ESUS patients graded as A2 or A3 (i.e. ipsilateral atherosclerotic plaque, contralateral ⩾ 50% stenosis, or aortic arch plaque) were at a significantly higher risk of composite vascular events than those graded as A0 (i.e. no atherosclerotic disease) (adjusted hazard ratio (95% confidence interval), 2.40 (1.01-5.72). No differences were observed in the event risk between patients with S3 (i.e. magnetic resonance imaging evidence of SVD) and S0 (i.e. no SVD) and between those with C2 or C3 (i.e. presence of any cardiac pathology) and C0 (i.e. no cardiac abnormalities).
Conclusions:
Atherosclerotic diseases corresponding to ASCOD grade A2 or A3 were predictive of recurrent vascular events in ESUS patients. Reclassification of ESUS using ASCOD phenotyping provides important clues for risk prediction and may guide optimal management strategies.
More Related Videos
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
06:45Author Spotlight: Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT) for NonInvasive Whole-Brain Imaging of Ischemic Stroke
Published on: June 2, 2023